Jalaesta 20 Tablet contains Escitalopram Oxalate 20 mg, a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). Escitalopram works by increasing the levels of serotonin, a neurotransmitter, in the brain, which helps improve mood, reduce anxiety, and restore emotional balance. This medication is prescribed to adults and should be used under medical supervision, with dosage adjustments based on therapeutic response and tolerability. Common side effects may include nausea, headache, dry mouth, insomnia, and dizziness, though these often diminish with continued use. Patients should be monitored for any signs of worsening depression, suicidal ideation, or unusual behavioral changes, particularly during the initial treatment phase or dose adjustments. Caution is advised when used concomitantly with other serotonergic drugs due to the risk of serotonin syndrome. Jalaesta 20 Tablet is contraindicated in patients with hypersensitivity to escitalopram or citalopram and should be used cautiously in individuals with a history of seizures, bipolar disorder, or hepatic impairment. Abrupt discontinuation should be avoided to prevent withdrawal symptoms. Always consult a healthcare professional before initiating or discontinuing therapy with Jalaesta 20 Tablet.